UCB Pharma SA
1,960.6 FTEThe score of UCB Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +40 % Equity +45 % Total assets +42 % Headcount (avg FTE) +43 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
UCB Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €4.62bn | ||||
| Net result | €4.24bn | ||||
| Equity | €16.2bn | ||||
| Cash | €7.87m | ||||
| EBITDA | €451.1m | ||||
| Total assets | €20.7bn |
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 May 2026
- Year ended 31 Dec 2024filed on 19 May 2025
- Year ended 31 Dec 2023filed on 13 May 2024
- Year ended 31 Dec 2022filed on 17 May 2023
- Year ended 31 Dec 2021filed on 23 May 2022
UCB Pharma's financial analysis
- Solvency78.3%sector median: 41.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of UCB Pharma
UCB Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0403.096.168
- VAT number
- BE0403096168
- Peppol
- Registered · 0208:0403096168 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 01 Feb 1968
- Registered office
- 1070 Anderlecht
- Size
- Large · 1,960.6 FTE
- Latest accounts
- 2025 · filed on 19 May 2026
- Activity
- Manufacture of medicaments (NACE 21201)
UCB Pharma (SA) has been based in Anderlecht since 1968, active in: manufacture of medicaments. For 2025, it reports revenue of €4.62bn, a net profit of €4.24bn and equity of €16.2bn. With 1,960.6 full-time equivalents, it is a large enterprise by headcount. Its solvency stands at 78.3%, above the median of its sector (41.4%).
Companies similar to UCB Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pfizer Manufacture of pharmaceutical preparations Ixelles · balance sheet €377.4m
- Organon Heist Manufacture of pharmaceutical preparations Heist-op-den-Berg · balance sheet €349.6m
- Ipsen Manufacture of pharmaceutical preparations Brussels · balance sheet €134.4m
- Laboratoires S.M.B. Manufacture of pharmaceutical preparations Molenbeek-Saint-Jean · balance sheet €261.5m
- Ceres Pharma Manufacture of other food products n.e.c. Ghent · balance sheet €265.9m
- GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline Wholesale of pharmaceutical and medical goods Wavre · balance sheet €58.2m
- Tilman Manufacture of pharmaceutical preparations Somme-Leuze · balance sheet €43.2m
- S.M.B. Technology Manufacture of pharmaceutical preparations Marche-en-Famenne · balance sheet €56.8m
Frequently asked questions about UCB Pharma
What is the revenue of UCB Pharma?
According to the 2025 annual accounts filed with the NBB, the revenue of UCB Pharma amounts to 4,622,639,386 €.
What is the VAT number of UCB Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0403096168 for UCB Pharma, if the company is VAT-registered. Its company number (CBE) is 0403.096.168.
Where is the registered office of UCB Pharma?
According to the CBE register, the registered office of UCB Pharma is in 1070 Anderlecht.
What is the equity of UCB Pharma?
At the close of the 2025 financial year, the equity of UCB Pharma amounts to 16,234,819,937 €, a solvency of 78.3% of total assets.
How many people work at UCB Pharma?
1,960.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages UCB Pharma?
The register lists 5 active mandates at UCB Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of UCB Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →